Abstract
Carbamazepine (CBZ) is an iminostilbene with a tricyclic structure. It has been in clinical use for more then twenty years and has often been considered the anticonvulsant of choice for women with seizure disorders who wish to have a pregnancy. This was based on small series of exposed women. Recently, Morrison and Rieder (1993) made a survey of the usual practice among Canadian neurologists with respect to the management of epilepsy during pregnancy. In a majority (75%) CBZ was mentioned as the drug of choice. Epidemiological studies published during the past five years indicate an increased risk for some adverse reproductive outcome, however.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barry, J. E., Danks, D. M. 1974. Anticonvulsants and congenital abnormalities. Lancet. ii: 48–49. (Letter)
Battino, D., Granata, T., Binelli, S., Caccamo, M. L., Canevini, M. P., Canger, R., Croci, D., Fumarola, C., Mai, R., Molteni, F., Pardi, G., and Avanzini, G. 1992a. Intrauterine growth in the offspring of epileptic mothers. Acta NeurolScand. 86: 555–557.
Battino, D., Binelli, S., Caccamo, M. L., Canevini, M. P., Canger, R., Como,. M. L., Croci, D., De Gianbattista, M., Granata, T. and Pardi, G. 1992b. Malformations in offspring of 315 epileptic women: a prospective study. Acta NeurolScand. 85: 204–207.
Bell, A. D., Gerlis, L. M., Variend, S. 1986. Persistent right umbilical vein. Case report and review of literature. In. J. Cardiol. 10: 167–176.
Bertollini, R., Källén, B., Mastroicacovo, P., and Robert, E. 1987. Anticonvulsant drugs in monotherapy. Effect on the fetus. Eur. J. Epidemiol. 3: 164–171.
Béthenod, M. and Frédérich, A. 1975. Les enfants des antiépileptiques. Pediatrie 230: 227–248.
Bjerkedal, T., Czeizel, A., Goujard, J., Kallen, B., Mastroiacovo, P., Nevin, N., Oakley, G. Jr., and Robert, E. 1982. Valproic acid and spina bifida. Lancetii: 1096. (Letter)
Bortnichak, E. A., and Wetter, M. S. 1989. Teratogenic effects of carbamazepine. N. Engl J. Med. 321: 1480. (Letter)
Chatot, C. L., Klein, N. W., Piateh, J., and Pierro, L. J. 1980. Successful culture of rat embryos on human serum: use in the detection of teratogens. Science 207: 1471–1473.
Chatot, C. L., Klein, N. W., Clapper, M. L., Resor, S. R., Singer, W. D., Russman, B. S., Holmes, G. L., Mattson, R. H., and Cramer, J. A. 1984. Human serum teratogenicity studied by rat embryo culture: epilepsy, anticonvulsant drugs, and nutrition. Epilepsia 25: 205–216.
Crawford, P. 1993. Epilepsy and pregnancy. Seizure 2: 87–90.
Dansky, L. V. 1989. Outcome of pregnancy in pregnant epileptic women. A prospective evaluation of genetic and environmental risk factors. Ph. D. Thesis, McGill University. (Quoted from Dansky and Finnell, 1991).
Dansky, L. V., and Finnell, R. H. 1991. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies. Reprod. Toxicol. 5: 301–335.
Dow, K. E., and Riopelle, R. J. 1989. Teratogenic effects of carbamazepine. N. Engl J. Med. 321: 1480–1481. (Letter)
Dravet, C., Julian, C., Legras, C., Magaudda, A., Guerrini, R., Genton, T., Soulayrol, S., Giraud, N., Mesdjian, E., Trentin, G., Roger, J., and Aymé, S. 1992. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 42: 75–82.
El-Sayed, M. G. A., Aly, A. E., Kadri, M., and Moustafa, A. M. 1983. Comparative study on the teratogenicity of some antiepileptics in the rat. East African Med. J. 60: 407–415.
Eluma, F. O., Sucheston, M. E., Hayes, T. G, and Paulson, R. B. 1984. Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-I mouse fetus. J. Craniofac. Genetics Dev. Biol 4: 191–210.
Fedrick, J. 1973. Epilepsy and pregnancy. A report from the Oxford linkage study. Brit. Med J. ii: 442–448.
Finnell, R. H., Mohl, V. K., Bennett, G. D., and Taylor, S. M. 1986. Failure of epoxide formation to influence carbamazepine-induced teratogenesis in a mouse model. Teratogen. Carcinogen. Mutagen. 6: 393–401.
Fritz, H., Müller, D., and Hess, R. 1976. Comparative study of the teratogenicity of phenobarbitone, diphenylhydantoin and carbamazepine in mice. Toxicology 6: 323–330.
Froescher, W., Eichelbaum, M., Niesen, M., Altmann, D., and von Unruh, G. E. 1980. Antiepileptic therapy with carbamazepine and valproic acid during pregnancy. Acta Neurol. Scand. Suppl 79. 62: 66–67. (Abstract).
Gladstone, DJ., Bologa, M., Maguire, C., Pastuszak, A., and Koren, G. 1992. Course of Pregnancy and Fetal Outcome Following Maternal Exposure to Carbamazepine and Phenytoin-A Prospective Study. Reprod. Toxicol. 6: 257–261.
Granström, M.-L., and Gaily, E. 1992. Psychomotor development in children of mothers with epilepsy.Neurology 42 Suppl. 5: 144–148.
Granström, M.-L., and Hiilesmaa, V. K. 1982. Malformations and minor anomalies in the children of epileptic mothers: preliminary results of the prospective Helsinki study. In: Epilepsy, Pregnancy, and the Child. Ed. by Janz, D., Dam, M., Richens, A., Bossi, L, Helge, H., and Schmidt, D. Raven Press, N. Y., pp. 303–307.
Hansson, J. W., Myrianthopoulos, M. C., Sedgwick Harvey, M. A., and Smith, D. W. 1976. Risks to the offspring of women treated with hydantoin anticonvulsants, which emphasis on the fetal hydantoin syndrome. J. Ped. 89: 662–668.
Hiilesmaa, V. K., Teramo, K., and Granström, M.-L. 1981. Fetal head growth retardation associated with maternal anti-epileptic drugs. Lancetii: 165–167.
Jain, S., and Maheshwari, M. C. 1991. A prolonged prospective follow-up study of 306 epileptic patients in New Delhi. Acta Neurol Scand. 84: 471–474.
Jones, K. L., Lacro, R. V., Johnson, K. A., and Adams, J. 1989. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N. Engl J. Med. 320: 1661–1666.
Källén, B. Maternal carbamazepine and infant spina bifida. 1994. Reprod. Toxicol. 8: in press.
Källén, B., Robert, E., Mastroiacovo, P., MartÍnez-FrÍas, M. L., Castilla, E. E., Cocchi, G. 1989. Anticonvulsant drugs and malformations. Is there a drug specificity? Eur. J. Epidemiol. 5: 31–36.
Kaneko, S., Otani, K., Kondo, T., Fukushima, Y., Nakamura, Y., Ogawa, Y., Kan, R., Takeda, A., Nakane Y., and Teranishi, T. 1992. Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 42: 68–74.
Keller, D. M. 1989. Teratogenic effects of carbamazepine. N Engl J. Med. 321: 1480. (Letter)
Koch, S., Losche, G., Jäger-Roman, E., Jakob, S., Rating, D., Deichl, A., and Helge, H. 1992. Major and minor birth malformations and antiepileptic drugs. Neurology 42 Suppl. 5: 83–88.
Leavitt, A. M., Yerby, M. S., Robinson, N., Sells, C. J., and Erickson, D. M. 1992. Epilepsy in pregnancy-developmental outcome of offspring at 12 months. Neurology 42 Suppl. 5: 141–143.
Lindhout, D. 1992. Pharmacogenetics and drug interactions: role in antiepileptic-drug-induced teratogenesis. Neurology 42 Suppl. 5: 43–47.
Lindhout, D., Meinardi, H., Meijer, J. W. A., and Nau, H. 1992a. Antiepileptic drugs and teratogenesis in two consecutive cohorts-changes in prescription policy paralleled by changes in pattern of malformations. Neurology 42 Suppl. 5: 94–110.
Lindhout, D., Omtzigt, J. G. C., and Cornel, M. C. 1992b. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 42: 111–118.
Lindhout, D., Verhoef, A., and Peters, P. W. J. 1985. Teratogenicity of antiepileptic drug combinations as assessed by whole rat embryo culture. Teratology 32: 27–28A. (Abstract)
Little, B. B., Santosramos, R, Newell, J. F, and Maberry, M. C. 1993. Megadose carbamazepine during the period of neural tube closure. Obst. Gynecol. 82: 705–708.
Majewski, F. 1985. Teratogens of major importance: alcohol and anticonvulsants. In: The Developing Brain and Its Disorders. Ed. by Arima, M., Suzuki, Y., Yabuuchi, H. S. Karger, Basel, pp. 223–246.
Marden, CM., Leach, M. J., and Wilson J. A. 1981. Effect of prenatal exposure to anticonvulsant agents on maternal and foetal folate concentrations in the rat. Brit. J. Pharmacol. 74: 957–958P.
Markestad, T., Ulstein, M., and Strandjord, R. E. 1984. Outcome of pregnancy in women with epilepsy. Acta Neurol. Scand. 69 Suppl. 98: 79–80.
Morrison, G, and Rieder, M. J. 1993. Practices of epilepsy during pregnancy-a survey of Canadian neurologists. Reprod. Toxicol. 7: 55–59.
Murasaki, O., Yoshitake, K., Tachiki, H., Nakane, Y., and Kaneko, S. 1988. Reexamination of the teratological effect of antiepileptic drugs. Jap. J. Psychiat. Neurol. 42: 592–593.
Nir, A., Weintraub, Z., Oliven, A., Kelener, J., and Lurie, M. 1990. Anatomic evidence of spontaneous intrauterine closure of a ventricular septal defect. Pediat. Cardiol. 11: 208–210.
Omtzigt, J. G. C., Los, F. J., Grobee, D. E., Pijpers, L., Jahoda, M. G. J., Brandenburg, H., Stewart, P. A., Gaillard, H. L. J., Sachs, E. S., Wladimiroff, J. W., and Lindhout, D. 1992a. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 42 Suppl. 5: 119–125.
Omtzigt, J. G. C., Los, F. J., Hagenaars, A. M., Stewart, P. A., Sachs, E. S., and Lindhout, D. 1992b. Prenatal diagnosis of spina-bifida-aperta after lst-trimester valproate exposure. Prenat. Diagn. 12: 893–897.
Omtzigt, J. G. C., Los, F. J., Meijer, J. W. A., and Lindhout, D. 1993. The 10, ll-epoxide-10, ll-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid-effect of dose, comedication, and relation to outcome of pregnancy. Ther. Drug. Monit. 15: 1–10.
Paulson, R. B., Paulson, G. W. and Jreissaty, S. 1979. Phenytoin and carbamazepine in the production of cleft palates in mice. Arch. Neurol. 36: 832–836.
Robertson, I. G. 1983. Cranial nerve agenesis in a fetus exposed to carbamazepine. Develop. Med. Child Neurol. 25: 540–541.
Rosa, F. W. 1983. Pregnancy outcomes with maternal carbamazepine exposure. FDA Adverse Drug Reaction Highlight-Al.
Rosa, F. W. 1991. Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 324: 674–677.
Scialli, A. R., and Lione, A. 1989. Teratogenic effects of carbamazepine. N. Engl J. Med. 321: 1480. (Letter)
Scolnik, D., Nulman, I., Rovet, J., Gladstone, D., Czuchta, D., Gardner, H. A., Gladstone, R., Ashby, P., Weksberg, R., Einarson, T., Koren, G. 1994. Neurodevelopment of chidlren exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271: 767–770.
Shakir, R. A., and Abdulwahab, B. 1991. Congenital malformations before and after the onset of maternal epilepsy. Acta Neurol. Scand. 84: 153–156.
Sibley, Y. D. L., Roberts, K. D., and Silove, E. D. 1986. Surgical correction of anomalous origin of right pulmonary artery from aorta in a four day old neonate. Br. Heart J. 56: 98–100.
Silver, K., Siavalas, EX., and Andermann, E. 1992. Outcome of children born to epileptic mothers: a prospective blinded study. Neurology 42 Suppl. 3: 287. (Abstract)
Starreveld-Zimmerman, A. A. E., Van der Kolk, W. J., Elshove, J., and Meinardi, H. 1974. Teratogenicity of antiepileptic drugs. Clin. Neurol. Neurosurg. 2: 81–95.
Strickler, S. M., Dansky, L. V., Miller, M. A., Seni, M.-H., Andermann, E., and Spielberg, S. P. 1985. Genetic predisposition to phenytoin-induced birth defects. Lancetii: 746–749.
Sullivan, F. M. and McElhatton, P. R. 1977. A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice. Toxicol Appl Pharmacol. 40: 365–378.
Tanganelli, P., and Regesta, G. 1992. Epilepsy, pregnancy and major birth anomalies: an Italian prospective, controlled study. Neurology 42 Suppl. 5: 89–93.
Van der Pol, M. C., Hadders-Algra, M., Huisjes, H. J., and Touwen, B. C. L. 1991. Antiepileptic medication in pregnancy: late effects on the children’s central nervous system development. AmJ. ObstetGynec. 164: 121–128.
Vorhees, C. V., Acuff, K. D., Weisenburger, W. P., and Minck, D. R. 1990. Teratogenicity of carbamazepine in rats. Teratology 41: 311–317.
West, J., Burke. J. P., and Strachan, I. 1990. Carbamazepine, epilepsy and optic nerve hypoplasia. Br. J. Ophthal. 74: 511. (Letter)
Wilder, B. J. 1992. Pharmacokinetics of valproate and carbamazepine. J. Clin. Psychopharmacol. 12: 64S–68S.
Wray, S. D., Hassell, T. M., Phillips, C., and Johnston, M. C. 1982. Preliminary study of the effects of carbamazepine on congenital orofacial defects in offspring of A/J mice. Epilepsia 23: 101–110
Yerby, M. S., Leavitt, A. M., Erickson, D. M., McCormick, K. B., Loewenson, R. B., Sells, C. J., and Benedetti, T. J. 1992. Antiepileptics and the development of congenital anomalies. Neurology 42: 132–140.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Robert, E., Källén, B. (1994). In Utero Exposure to Carbamazepine Effects on the Fetus. In: Kalter, H. (eds) Issues and Reviews in Teratology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2512-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2512-7_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6069-8
Online ISBN: 978-1-4615-2512-7
eBook Packages: Springer Book Archive